2009
DOI: 10.1051/mmnp/20094206
|View full text |Cite
|
Sign up to set email alerts
|

New Computational Tools for Modeling Chronic Myelogenous Leukemia

Abstract: Abstract. In this paper, we consider a system of nonlinear delay-differential equations (DDEs) which models the dynamics of the interaction between chronic myelogenous leukemia (CML), imatinib, and the anti-leukemia immune response. Because of the chaotic nature of the dynamics and the sparse nature of experimental data, we look for ways to use computation to analyze the model without employing direct numerical simulation. In particular, we develop several tools using Lyapunov-Krasovskii analysis that allow us… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2014
2014
2021
2021

Publication Types

Select...
3
1
1

Relationship

0
5

Authors

Journals

citations
Cited by 10 publications
(1 citation statement)
references
References 38 publications
0
1
0
Order By: Relevance
“…Even if a variety of mathematical papers have applied a range of modeling approaches to study tumor-immune interactions in general (see, for example the recent review [7]), only a few described the specific leukemia-immune interaction. Leukemia-immune models have been formulated using mostly ordinary differential equations (ODE) ( [16], [17]) or delay differential equations (DDE) ( [2], [5], [12], [19]). Some models that specifically study the immune response to CML are [12], [2], [18] and [16].…”
Section: Introductionmentioning
confidence: 99%
“…Even if a variety of mathematical papers have applied a range of modeling approaches to study tumor-immune interactions in general (see, for example the recent review [7]), only a few described the specific leukemia-immune interaction. Leukemia-immune models have been formulated using mostly ordinary differential equations (ODE) ( [16], [17]) or delay differential equations (DDE) ( [2], [5], [12], [19]). Some models that specifically study the immune response to CML are [12], [2], [18] and [16].…”
Section: Introductionmentioning
confidence: 99%